Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin and Alkali Therapy in ADPKD
NCT04284657Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Jan 2019
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pravastatin, trisodium citrate in autosomal dominant polycystic kidney disease (ADPKD), sponsored by University of Southern California. Started Jan 2019; status: completed.
02
Drugs
pravastatintrisodium citrate
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT04284657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04284657.